Kiniksa Pharmaceuticals International Plc. Total Assets

Kiniksa Pharmaceuticals International Plc. (KNSA) currently reports a total assets of $900M as of June 2026. That compares with $660M in the prior-year period — up 35.5% year over year. Use the charts on this page to explore Kiniksa Pharmaceuticals International Plc.'s total assets history and peer comparisons.

Kiniksa Pharmaceuticals International Plc.'s total assets increased from $660M to $900M — a 35.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiniksa Pharmaceuticals International Plc. reported $900M in total assets as of June 2026. That compares with $660M in the prior-year period — up 35.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $900M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiniksa Pharmaceuticals International Plc., and consider following KNSA for alerts when major investors trade the stock.

Kiniksa Pharmaceuticals International Plc. is classified in the Healthcare sector. On total assets, it currently shows $900M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KNSA with unrelated industries.